Holding(s) in Company

RNS Number : 4674U

Instem Life Science Systems plc

15 October 2010

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Instem Life Science Systems plc

2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights		√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	ACQUISITION OF VOTING RIGHTS FOLLOWING THE RECENT PLACING.	√

3. Full name of person(s) subject to the notification obligation:	Aviva plc & its subsidiaries
4. Full name of shareholder(s) (if different from 3.):	Registered Holder: BNY Norwich Union Nominees Limited 76,000* Chase (GA Group) Nominees Limited  495,429* *denotes direct interest
5. Date of the transaction and date on which the threshold is crossed or reached:	13 October 2010
6. Date on which issuer notified:	14 October 2010
7. Threshold(s) that is/are crossed or reached:	0% to 4% Change at Direct Interest Level

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of  voting rights
			Direct	Direct	Indirect	Direct	Indirect
Ordinary Shares	Nil	Nil	571,429	571,429	Nil	4.88%	Nil
B00B3TQCK30

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ Conversion Period	Number of voting rights that may be acquired if the instrument is exercised/ converted.	% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date	Exercise/ Conversion period	Number of voting rights instrument refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)
Number of voting rights	Percentage of voting rights
571,429	4.88%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: ·      Aviva plc (Parent Company) ·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) ·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

Proxy Voting:
10. Name of the proxy holder:	See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	Figures are based on a total number of voting rights of 11,714,286.
14. Contact name:	Neil Whittaker
15. Contact telephone number:	01603 684420

 

END

 

 

HOLMABLTMBJBMFM